Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5791781, 7 pages
https://doi.org/10.1155/2017/5791781
Research Article

Antimicrobial Activity of Quinazolin Derivatives of 1,2-Di(quinazolin-4-yl)diselane against Mycobacteria

1School of Life Science, Institute of Neurobiology, Anhui Key Laboratory of Infection and Immunity, Bengbu Medical College, Bengbu 233030, China
2Department of Physiology, Bengbu Medical College, Bengbu 233030, China
3Scientific Research Center, Bengbu Medical College, Bengbu 233030, China
4Department of Microbiology and Parasitology, Anhui Key Laboratory of Infection and Immunity, Bengbu Medical College, Bengbu 233030, China

Correspondence should be addressed to Bikui Tang; moc.liamg@cmbb.gnatkb and Yinjiu Huang; nc.anis@3791gnauhuijniy

Received 11 December 2016; Revised 12 March 2017; Accepted 3 April 2017; Published 22 May 2017

Academic Editor: Isabel Portugal

Copyright © 2017 Bikui Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Tuberculosis Report, World Health Organization, 2016.
  2. Beena and D. S. Rawat, “Antituberculosis drug research: a critical overview,” Medicinal Research Reviews, vol. 33, no. 4, pp. 693–764, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Galli, L. Lancella, S. Garazzino et al., “Recommendations for treating children with drug-resistant tuberculosis,” Pharmacological Research, vol. 105, pp. 176–182, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Preiss, J. D. Langer, Ö. Yildiz et al., “Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline,” Science Advances, vol. 1, no. 4, Article ID e1500106, 2015. View at Publisher · View at Google Scholar
  5. K. K. Harris, A. Fay, H.-G. Yan et al., “Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant gram-positive cocci,” ACS Chemical Biology, vol. 9, no. 11, pp. 2572–2583, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. L. L. Ling, T. Schneider, A. J. Peoples et al., “A new antibiotic kills pathogens without detectable resistance,” Nature, vol. 517, no. 7535, pp. 455–459, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-J. Huang, Y.-Y. Zhang, G. Liu et al., “Preliminary evaluation of the in vitro efficacy of 1, 2-di (quinazolin-4-yl) diselane against SiHa cervical cancer cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 15, pp. 6301–6306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Huang, X. Hu, G. Liu et al., “A potential anticancer agent 1,2-di(quinazolin-4-yl)diselane induces apoptosis in non-small-cell lung cancer A549 cells,” Medicinal Chemistry Research, vol. 24, no. 5, pp. 2085–2096, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Huang, H. Xie, G. Liu et al., “To preliminarily evaluate the anticancer activiy of 1,2-di(quinazolin-4-yl)diselane against MDA-MB-435 cells in vitro,” Letters in Drug Design and Discovery, vol. 11, no. 9, pp. 1090–1095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Chen, W. Yang, and X. Yang, “Effects of 1,2-di(quinazolin-4-yl)diselane inhibited Toxoplasma in vitro,” Chinese Journal of Zoonoses, vol. 29, pp. 692–697, 2013. View at Google Scholar
  11. Y. Huang, G. Liu, X. Hu et al., “A potential anticancer agent 1,2-di(quinazolin-4-yl)diselane,” Letters in Drug Design & Discovery, vol. 11, no. 6, pp. 731–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Vilchèze, T. Hartman, B. Weinrick, and W. R. Jacobs Jr., “Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction,” Nature Communications, vol. 4, article 1881, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Bald and A. Koul, “Respiratory ATP synthesis: the new generation of mycobacterial drug targets?” FEMS Microbiology Letters, vol. 308, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Lobritz, P. Belenky, C. B. M. Porter et al., “Antibiotic efficacy is linked to bacterial cellular respiration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 27, pp. 8173–8180, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Andries, P. Verhasselt, J. Guillemont et al., “A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis,” Science, vol. 307, no. 5707, pp. 223–227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Balemans, L. Vranckx, N. Lounis et al., “Novel antibiotics targeting respiratory ATP synthesis in gram-positive pathogenic bacteria,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 8, pp. 4131–4139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. P. S. Rao, S. Alonso, L. Rand, T. Dick, and K. Pethe, “The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 33, pp. 11945–11950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Glickman, “Double-strand DNA break repair in mycobacteria,” Microbiology Spectrum, vol. 2, no. 5, Article ID MGM2-0024-2013, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. E. Heaton, D. Barkan, P. Bongiorno, P. C. Karakousis, and M. S. Glickman, “Deficiency of double-strand DNA break repair does not impair Mycobacterium tuberculosis virulence in multiple animal models of infection,” Infection and Immunity, vol. 82, no. 8, pp. 3177–3185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Kohanski, D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins, “A common mechanism of cellular death induced by bactericidal antibiotics,” Cell, vol. 130, no. 5, pp. 797–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Keren, Y. Wu, J. Inocencio, L. R. Mulcahy, and K. Lewis, “Killing by bactericidal antibiotics does not depend on reactive oxygen species,” Science, vol. 339, no. 6124, pp. 1213–1216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Liu and J. A. Imlay, “Cell death from antibiotics without the involvement of reactive oxygen species,” Science, vol. 339, no. 6124, pp. 1210–1213, 2013. View at Publisher · View at Google Scholar · View at Scopus